Key immunization stakeholders from around Asia gathered in Bangladesh to learn from each other and raise the urgency to take on typhoid now
Typhoid takes a spotlight during the 2022 VASE Conference
Test-negative design proves to be suitable for typhoid vaccine effectiveness evaluations
Cost-effectiveness
Is the routine use of typhoid conjugate vaccines (TCVs) a cost-effective solution for countries? Should countries apply for TCV support from Gavi, the Vaccine Alliance? How should TCVs be introduced? ...
Drug-Resistant Typhoid
Appropriate antibiotics, which first became available in the 1940s, are the only effective way to treat typhoid. The disease is caused by a quickly-evolving bacterium that has developed defenses against ...
